Covishield vaccine trials commence in Chennai

A total of 300 volunteers are to be involved in the trial

September 29, 2020 02:17 pm | Updated 02:25 pm IST - CHENNAI

Photograph used for representational purposes only

Photograph used for representational purposes only

The phase two trial of Oxford University’s COVID-19 vaccine, Covishield, has commenced in Chennai.

While confirming that the vaccine trials have begun in Chennai, officials of the Health Department refused to divulge any further details.

The trial that is being carried out by the Indian Council of Medical Research and the National Institute for Research in Tuberculosis, involves two institutions in the city -- Rajiv Gandhi Government General Hospital and Sri Ramachandra Institute of Higher Education and Research. A total of 300 volunteers would be involved in the trial, a press release issued earlier by the Health Department said.

The Directorate of Public Health and Preventive Medicine had called for volunteers for enrolment in the trial (phase two/three observer -- blind randomised, controlled study to determine the safety and immunogenicity of Covishield in healthy Indian adults). About 200 vials of the vaccine had arrived in the city during the first week of September.

Top News Today


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.